For research use only. Not for therapeutic Use.
Orziloben(CAT: I040771) is a small-molecule compound identified as a selective PDE10A (phosphodiesterase 10A) inhibitor, primarily expressed in the striatum region of the brain. By inhibiting PDE10A, Orziloben increases intracellular levels of cAMP and cGMP, modulating neuronal signaling pathways involved in motor control, cognition, and mood regulation. This compound has shown potential in the treatment of neuropsychiatric and neurodegenerative disorders, including schizophrenia, Huntington’s disease, and Parkinson’s disease. Orziloben is a valuable research tool for exploring PDE10A-related pathways and developing novel central nervous system (CNS) therapeutics aimed at improving cognitive and behavioral outcomes.
| CAS Number | 1555822-28-0 |
| Synonyms | 2-methyl-3-pentoxybenzoic acid |
| Molecular Formula | C13H18O3 |
| Purity | ≥95% |
| IUPAC Name | 2-methyl-3-pentoxybenzoic acid |
| InChI | InChI=1S/C13H18O3/c1-3-4-5-9-16-12-8-6-7-11(10(12)2)13(14)15/h6-8H,3-5,9H2,1-2H3,(H,14,15) |
| InChIKey | JYEFZVSYKCEGEE-UHFFFAOYSA-N |
| SMILES | CCCCCOC1=CC=CC(=C1C)C(=O)O |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
